Therapy (Cancer)

Stem Cell Clinical Trial Initiated in Europe

Published in Blood Weekly, March 24th, 1997

Aastrom Biosciences, Inc. (Aastrom), Ann Arbor, Michigan, and Cobe BCT, Lakewood, Colorado, announced the initiation of a European clinical trial to evaluate the use of the Aastrom Cell Production System (Aastrom CPS) in the production of bone marrow stem cells.

The Aastrom CPS has been planned for use to promote the recovery of white blood cells in breast cancer patients undergoing aggressive multiple-cycle myelosuppressive chemotherapy.

"Initiation of this clinical trial represents an important advancement in the development of the Aastrom CPS. This trial is designed to demonstrate the ability of Aastrom CPS produced stem cells to reduce the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (1997-03-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry